LGJun 14, 2025
EXGnet: a single-lead explainable-AI guided multiresolution network with train-only quantitative features for trustworthy ECG arrhythmia classificationTushar Talukder Showrav, Soyabul Islam Lincoln, Md. Kamrul Hasan
Deep learning has significantly propelled the performance of ECG arrhythmia classification, yet its clinical adoption remains hindered by challenges in interpretability and deployment on resource-constrained edge devices. To bridge this gap, we propose EXGnet, a novel and reliable ECG arrhythmia classification network tailored for single-lead signals, specifically designed to balance high accuracy, explainability, and edge compatibility. EXGnet integrates XAI supervision during training via a normalized cross-correlation based loss, directing the model's attention to clinically relevant ECG regions, similar to a cardiologist's focus. This supervision is driven by automatically generated ground truth, derived through an innovative heart rate variability-based approach, without the need for manual annotation. To enhance classification accuracy without compromising deployment simplicity, we incorporate quantitative ECG features during training. These enrich the model with multi-domain knowledge but are excluded during inference, keeping the model lightweight for edge deployment. Additionally, we introduce an innovative multiresolution block to efficiently capture both short and long-term signal features while maintaining computational efficiency. Rigorous evaluation on the Chapman and Ningbo benchmark datasets validates the supremacy of EXGnet, which achieves average five-fold accuracies of 98.762% and 96.932%, and F1-scores of 97.910% and 95.527%, respectively. Comprehensive ablation studies and both quantitative and qualitative interpretability assessment confirm that the XAI guidance is pivotal, demonstrably enhancing the model's focus and trustworthiness. Overall, EXGnet sets a new benchmark by combining high-performance arrhythmia classification with interpretability, paving the way for more trustworthy and accessible portable ECG based health monitoring systems.
IVMay 20, 2025
XDementNET: An Explainable Attention Based Deep Convolutional Network to Detect Alzheimer Progression from MRI dataSoyabul Islam Lincoln, Mirza Mohd Shahriar Maswood
A common neurodegenerative disease, Alzheimer's disease requires a precise diagnosis and efficient treatment, particularly in light of escalating healthcare expenses and the expanding use of artificial intelligence in medical diagnostics. Many recent studies shows that the combination of brain Magnetic Resonance Imaging (MRI) and deep neural networks have achieved promising results for diagnosing AD. Using deep convolutional neural networks, this paper introduces a novel deep learning architecture that incorporates multiresidual blocks, specialized spatial attention blocks, grouped query attention, and multi-head attention. The study assessed the model's performance on four publicly accessible datasets and concentrated on identifying binary and multiclass issues across various categories. This paper also takes into account of the explainability of AD's progression and compared with state-of-the-art methods namely Gradient Class Activation Mapping (GradCAM), Score-CAM, Faster Score-CAM, and XGRADCAM. Our methodology consistently outperforms current approaches, achieving 99.66\% accuracy in 4-class classification, 99.63\% in 3-class classification, and 100\% in binary classification using Kaggle datasets. For Open Access Series of Imaging Studies (OASIS) datasets the accuracies are 99.92\%, 99.90\%, and 99.95\% respectively. The Alzheimer's Disease Neuroimaging Initiative-1 (ADNI-1) dataset was used for experiments in three planes (axial, sagittal, and coronal) and a combination of all planes. The study achieved accuracies of 99.08\% for axis, 99.85\% for sagittal, 99.5\% for coronal, and 99.17\% for all axis, and 97.79\% and 8.60\% respectively for ADNI-2. The network's ability to retrieve important information from MRI images is demonstrated by its excellent accuracy in categorizing AD stages.